Tuoran Pharma
中科拓苒
Tuoran Pharma
Biotech/Healthcare
Zhongke Tuoran develops targeted novel therapeutics. Its proprietary innovative drug pipeline covers oncology, autoimmune diseases, and inflammatory conditions, with two Class 1 innovative drugs currently at the IND filing stage.
Latest round: Series B (2022)
Source: ChinaBulls — chinabulls.com
Last updated 2022-02-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.